Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a colorless liquid when formulated for injection. The addition of cyanocobalamin, commonly known as vitamin B12, can impart a slight pink or reddish hue to the solution, depending on the concentration of B12. Some compounded formulations may also contain other ingredients that could subtly influence the final color.
Combining these two agents in a single injection can offer practical benefits for patients managing chronic conditions. While semaglutide is primarily used for treating type 2 diabetes and obesity, B12 plays a crucial role in nerve function and red blood cell production. Deficiencies in B12 can lead to various health issues, and supplementation can be particularly relevant for certain individuals, such as those on long-term metformin therapy for diabetes. This combined approach may improve patient adherence by reducing the number of required injections.
